• Life Arc invests £1m in University of Cambridge spin-out PolyProx pharmaceutical-technology
    March 03, 2020
    University of Cambridge Department of Pharmacology spin-out PolyProx Therapeutics has received £1m in seed capital from translation-focused medical research charity Life Arc.
  • seed financing pharmaceutical-technology
    May 05, 2019
    University of Cambridge spin out PolyProx Therapeutics has announced it has raised £3.4m of seed capital, led by Cambridge Innovation Capital (CIC), RT Capital and Cambridge Enterprise.
PharmaSources Customer Service